Eli Lilly (NYSE:LLY) – Eli Lilly’s experimental Alzheimer’s drug, donanemab, has received...
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.